Search results
Added:
9 months ago
Source:
Radcliffe Cardiology
Early withdrawal of aspirin in favour of potent P2Y12 inhibitor monotherapy following percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) did not meet the criteria for noninferiority regarding ischaemic events compared to standard dual antiplatelet therapy (DAPT), according to the results of the NEO-MINDSET trial.¹ The strategy did, however, demonstrate superiority in…
View more
Ardawan Julian Rastan
Job title: Staff Cardiac Surgeon at the Department of Cardiac Surgery
Author
Sex Differences in Heart Failure: A Step Forward
Author(s):
Sachintha Wijesinghe
,
Marie-Luise Dikou
,
Ioannis Kasouridis
,
et al
Added:
1 year ago
Review Article
Author(s):
Brian Bergmark
Added:
2 weeks ago
EuroPCR 2026 – Dr Brian Bergmark (Brigham and Women's Hospital, Boston, MA, US) joins us to discuss findings from the VESALIUS-CV trial, examining the effect of evolocumab in patients who have undergone coronary stenting but have no prior myocardial infarction or stroke.VESALIUS-CV is a double-blind, randomised, placebo-controlled, multicentre phase 3 trial enrolling 12,301 high-cardiovascular…
View more
Author(s):
Carolina Álvarez-Ortega
,
Josué Daniel Gómez-Martínez
,
María Alejandra Cardona-Gallardo
,
et al
Added:
2 years ago
Giuseppe Tarantini
Research Area(s) / Expertise:
Author
Added:
6 months ago
Source:
Radcliffe Cardiology
A study has found that while the severity of ischaemia correlates poorly with daily angina symptoms in patients with stable coronary artery disease (CAD), the development of coronary collateral circulation is associated with both the ischaemic burden and reduced intensity of ischaemic chest pain.¹ This may help explain the often-observed disconnect between stenosis severity and patient-reported…
View more
Deborah Siegal
Job title: Hematologist
Author
Added:
10 months ago
Source:
Radcliffe Cardiology
For patients with suspected angina with non-obstructive coronary arteries (ANOCA) or ischaemia with non-obstructive coronary arteries (INOCA), the diagnostic pathway can be challenging. A new study suggests that while exercise electrocardiography stress testing (EST) has limited ability to confirm underlying microvascular disease, its high negative predictive value makes it a valuable tool for…
View more
Author(s):
Gianluca Campo
Added:
1 year ago
ESC Congress 2024 — Complete revascularisation is safe, reduces ischemic events for up to 4 years, and does not affect long-term mortality.We are joined onsite by Dr Gianluca Campo (University of Ferrara, Ferrara, IT) to discuss the findings from EARTH-STEMI. Previous RCTs have supported the benefit of complete revascularisation in the overall population, however, this has not been confirmed in…
View more